Physician profile
Cora Pyles
NPI 1720711823
$766.49
in general payments reported to CMS, 2019-2025
12 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $87.32 · 2024: $324 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $208.59 | 2024-2025 | |
| Exact Sciences Corporation | $110.61 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Novo Nordisk INC | $104.43 | 2023-2025 | Wegovy |
| Gilead Sciences, INC. | $64.06 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $57.87 | 2025 | |
| Alexion Pharmaceuticals, INC. | $51.11 | 2024 | |
| Glaxosmithkline, LLC. | $48.67 | 2023 | Arexvy, Rotarix, Menveo |
| Phathom Pharmaceuticals, INC. | $32.46 | 2024 | Voquezna |
| Sanofi-Aventis U.S. LLC | $28.07 | 2025 | |
| Lilly USA, LLC | $20.32 | 2025 | Zepbound, Mounjaro |
| Organon LLC | $20.21 | 2024 | |
| Medtronic, INC. | $20.09 | 2023 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cora Pyles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.